Biohaven Pharmaceutical Holding Co. Ltd.(NYSE : BHVN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.19% | 160.39 | 0.7% | $1219.30m | |
| PFE | Pfizer Inc. | -0.01% | 37.60 | 0.9% | $1016.11m | |
| MRK | Merck & Co., Inc. | -0.01% | 76.66 | 0.7% | $965.59m | |
| ABBV | AbbVie, Inc. | -0.01% | 106.89 | 1.9% | $827.95m | |
| BMY | Bristol-Myers Squibb Co. | -0.02% | 64.44 | 1.0% | $731.63m | |
| LLY | Eli Lilly & Co. | -0.05% | 185.92 | 1.1% | $577.25m | |
| AZN | AstraZeneca Plc | 0.00% | 50.83 | 1.2% | $442.51m | |
| GSK | GlaxoSmithKline Plc | 0.05% | 37.69 | 0.2% | $214.10m | |
| RPRX | Royalty Pharma Plc | 0.00% | 41.65 | 0.2% | $157.73m | |
| NVS | Novartis AG | 0.28% | 87.44 | 0.2% | $153.88m | |
| VTRS | Viatris, Inc. | 0.00% | 13.28 | 0.0% | $128.16m | |
| CVAC | CureVac NV | 3.81% | 108.01 | 0.0% | $90.79m | |
| RGEN | Repligen Corp. | 0.00% | 213.57 | 6.8% | $89.09m | |
| SNY | Sanofi | 0.00% | 50.69 | 0.2% | $60.91m | |
| ATNF | 180 Life Sciences Corp. | -0.40% | 10.00 | 0.0% | $60.56m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.